Bristol-Myers Squibb Co

Latest in Bristol-Myers Squibb Co

FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
by thinkia.org.in 6 months ago
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s …
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
by thinkia.org.in 6 months ago
Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough. Bristol Myers Squibb, AstraZeneca, …
What’s next for the Biden administration’s Medicare drug price negotiations
by thinkia.org.in 7 months ago
U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event on Medicare drug price negotiations, …
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
by thinkia.org.in 8 months ago
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman …
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
by thinkia.org.in 9 months ago
Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, …
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
by thinkia.org.in 11 months ago
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman …
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
by thinkia.org.in 11 months ago
Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link …

Bristol-Myers Squibb Co

These are the two big things we’re watching in the stock market in the week ahead

Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

Latest in Bristol-Myers Squibb Co

FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

What’s next for the Biden administration’s Medicare drug price negotiations

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

Editors' Picks

Google might’ve accidentally approved an ad for a Target gift card scam

Latest Posts

Follow us